Increased sensitivity to SMAC mimetic LCL161 identified by longitudinal ex vivo pharmacogenomics of recurrent, KRAS mutated rectal cancer liver metastases by Kushtrim Kryeziu, Seyed H. Moosavi, Christian H. Bergsland, Marianne G. Guren, Peter W. Eide, Max Z. Totland, Kristoffer Lassen, Andreas Abildgaard, Arild Nesbakken, Anita Sveen, Ragnhild A. Lothe

Subjects: Get full text

An Updated Review of Smac Mimetics, LCL161, Birinapant, and GDC-0152 in Cancer Treatment by Yung-Chieh Chang, Chun Hei Antonio Cheung

Subjects: Get full text

Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma by Sunisa Prasopporn, Sunisa Prasopporn, Orawan Suppramote, Orawan Suppramote, Ben Ponvilawan, Chanette Jamyuang, Jantappapa Chanthercrob, Amphun Chaiboonchoe, Pimkanya More-Krong, Kamonchanok Kongsri, Monthira Suntiparpluacha, Rawisak Chanwat, Krittiya Korphaisarn, Seiji Okada, Somponnat Sampattavanich, Somponnat Sampattavanich, Siwanon Jirawatnotai, Siwanon Jirawatnotai

Subjects: Get full text

OTUD7B suppresses Smac mimetic-induced lung cancer cell invasion and migration via deubiquitinating TRAF3 by Boxiang Zhang, Chengcheng Yang, Rui Wang, Jie Wu, Yunfeng Zhang, Dapeng Liu, Xin Sun, Xiang Li, Hong Ren, Sida Qin

Subjects: Get full text

LCL161 enhances expansion and survival of engineered anti-tumor T cells but is restricted by death signaling by Arya Afsahi, Arya Afsahi, Arya Afsahi, Christopher M. Silvestri, Christopher M. Silvestri, Christopher M. Silvestri, Allyson E. Moore, Allyson E. Moore, Allyson E. Moore, Carly F. Graham, Carly F. Graham, Carly F. Graham, Kaylyn Bacchiochi, Kaylyn Bacchiochi, Martine St-Jean, Christopher L. Baker, Christopher L. Baker, Christopher L. Baker, Robert G. Korneluk, Shawn T. Beug, Shawn T. Beug, Shawn T. Beug, Eric C. LaCasse, Jonathan L. Bramson, Jonathan L. Bramson, Jonathan L. Bramson

Subjects: Get full text

Corrigendum: Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma by Sunisa Prasopporn, Sunisa Prasopporn, Orawan Suppramote, Orawan Suppramote, Ben Ponvilawan, Chanette Jamyuang, Jantappapa Chanthercrob, Amphun Chaiboonchoe, Pimkanya More-Krong, Kamonchanok Kongsri, Monthira Suntiparpluacha, Rawisak Chanwat, Krittiya Korphaisarn, Seiji Okada, Somponnat Sampattavanich, Somponnat Sampattavanich, Siwanon Jirawatnotai, Siwanon Jirawatnotai

Subjects: Get full text